In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused worldwide disruption, causing over 5.21 million deaths and shutting down the global economy for months. The virus deserves ...